[ccpw id="5"]

Home.forex news reportEncore: This CEO Says Humanoid Robots Are The "Space Race" of Our...

Encore: This CEO Says Humanoid Robots Are The "Space Race" of Our Time

-


Who will take care of you in old age? Jeff Cardenas, the CEO and co-founder of Apptronik, says the answer is robots. The startup founder set out to build a smart, dexterous robot after watching his grandfathers grow old and dependent in their later years. Beyond healthcare, Cardenas sees robots as essential to U.S. economic growth and national security with applications across industries. Even with the latest advances in artificial intelligence and hardware, what will it take for humanoid robots to make the leap from science fiction to reality? On the latest episode of the Bold Names podcast, Cardenas tells WSJ’s Christopher Mims and Tim Higgins why Apptronik is betting it will create the home robot helper that everyone will want.

To watch the video version of this episode, visit our WSJ Podcasts YouTube channel or the video page of WSJ.com.

Check Out Past Episodes:

Condoleezza Rice on Beating China in the Tech Race: ‘Run Hard and Run Fast’

Reid Hoffman Says AI Isn’t an ‘Arms Race,’ but America Needs to Win

Why This Investor Says the AI Boom Isn’t the Next Dot-Com Crash

How the U.S. Stacks Up to China’s ‘Engineering State’

Let us know what you think of the show. Email us at BoldNames@wsj.com.

Sign up for the WSJ’s free Technology newsletter.

Read Christopher Mims’s Keywords column.Read Tim Higgins’s column

Learn more about your ad choices. Visit megaphone.fm/adchoices



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

What Makes Amazon.com (AMZN) an Undervalued Quality Company?

Rothschild & Co Wealth Management, an investment management company, released its LongRun Equity strategy third-quarter 2025 investor letter. A copy of...

TNB Tech Minute: India’s Coforge to Acquire AI Software Firm Encora

Plus: Nvidia and Coupang shares jump. And analysts say Samsung Electronics and SK Hynix could benefit from DRAM demand. Julie Chang hosts. Learn more...

Is Synopsys (SNPS) an Attractive Investment Choice?

Rothschild & Co Wealth Management, an investment management company, released its LongRun Equity strategy third-quarter 2025 investor letter. A copy of...

As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?

Novo Nordisk A/S ADR (NVO), a trailblazer in the weight-loss revolution, has endured a bruising 2025. The Danish pharma giant...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img